Nisha Nanda Net Worth

What's Nisha Nanda's mailing address?

Nisha's mailing address filed with the SEC is 281 Tresser Blvd, Floor 9, Stamford, CT 06901, United States.

Insiders trading at Morphic Inc

Over the last 5 years, insiders at Morphic Inc have traded over 69,316,197$ worth of Morphic Inc stock and bought 3,360,997 units worth 101,882,696$ . The most active insiders traders include Plc Gsk、Holdings A/S Novo、Timothy A Springer. On average, Morphic Inc executives and independent directors trade stock every 13 days with the average trade being worth of 2,254,353$. The most recent stock trade was executed by Bruce Rogers on 8 July 2024, trading 20,000 units of MORF stock currently worth 86,400$.

What does Morphic Inc do?

oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. morphic tx is joining a three decade quest led by our scientific founder, tim springer, who initially discovered the integrin receptor family in the 1980s. this receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, crohn's disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention. despite blockbuster commercial success, integrins have remained out of reach as small molecule drugs...until now.

Morphic Inc executives and stock owners

Morphic Inc executives and other stock owners filed with the SEC include:

• Timothy Springer,
  Founder, Independent Director
• Alexey Lugovskoy,
  Chief Development Officer
• Dr. Praveen P. Tipirneni M.D.,
  CEO, Pres & Director
• William DeVaul,
  General Counsel, Secretary
• Praveen Tipirneni,
  President, Chief Executive Officer, Director
• Dr. Marc Schegerin M.B.A., M.D.,
  CFO & COO
• Bruce Rogers,
  Chief Scientific Officer
• Vikas Goyal,
  Independent Director
• Gustav Christensen,
  Independent Chairman of the Board
• Joseph Slattery,
  Independent Director
• Otello Stampacchia,
  Independent Director
• Norbert Bischofberger,
  Independent Director
• Amir Nashat,
  Independent Director
• Dr. Timothy A. Springer Ph.D.,
  Founder, Independent Director & Member of Scientific Advisory Board
• Nilesh Kumar,
  Independent Director
• Peter Linde,
  Chief Medical Officer
• Robert Farrell,
  Senior Vice President - Finance, Chief Accounting Officer
• Marc Schegerin,
  Chief Financial Officer, Chief Operating Officer
• Adrian S. Ray Ph.D.,
  Sr. VP and Head of Biology & Translation
• Blaise Lippa,
  Sr. VP of Molecular Discovery
• William D. DeVaul Esq.,
  Gen. Counsel & Sec.
• Dr. Bruce N. Rogers,
  Chief Scientific Officer
• Robert E. Farrell Jr., CPA, CPA,
  Sr. VP of Fin./Operations & Chief Accounting Officer
• Susannah Gray,
  
• Nisha Nanda,
  
• Martin Edwards,
  
• Holdings A/S Novo,
  10% owner
• Plc Gsk,
  Director
• Otello Stampacchia,
  Director
• Fund V, L.P.Omega Fund V Gp...,
  
• Simon Peter Cooper,
  CMO